Author： McCubrey James A Steelman Linda S Abrams Steven L Chappell William H Russo Suzanne Ove Roger Milella Michele Tafuri Agostino Lunghi Paolo Bonati Antonio Stivala Franca Nicoletti Ferdinando Libra Massimo Martelli Alberto M Montalto Giuseppe Cervello Melchiorre
Publisher： Informa Healthcare
ISSN： 1472-8214
Source： Expert Opinion on Emerging Drugs, Vol.14, Iss.4, 2009-12, pp. : 633-648
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 12, 1998-12 ,pp. :
Access to resources
Recommend
RAS/RAF/MEK Inhibitors in Oncology
Current Medicinal Chemistry, Vol. 19, Iss. 8, 2012-03 ,pp. :
Ras/Raf signalling and emerging pharmacotherapeutic targets
By Kolch Walter
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 6, 2002-06 ,pp. :
New RAF kinase inhibitors in cancer therapy
By Martin-Liberal Juan Larkin James
Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 9, 2014-06 ,pp. :